Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by alleyesonmeon Nov 29, 2022 11:11pm
143 Views
Post# 35138630

RE:BIG PRESS RELEASE IS ON THE WAY!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

RE:BIG PRESS RELEASE IS ON THE WAY!!!!!!!!!!!!!!!!!!!!!!!!!!!!!Yes, here's the deal. We know the Abbreviated new drug application uses medipharms natural CBD masterfile file for the active pharmaceutical ingredient...therfore the Abbreviated new drug (slightly different but the same as) is..cannabinol.A.K.A CBD..A.K.A Epidiolex (the pharmaceutical name registered and approved by the F.D.A)....this alone is very exciting...the first and only generic epidiolex...the secrets are...who is the global pharmaceutical company?....and MOST Importantly...is this a NEW INDICATION for treatment discovered through successful clinical trials.... Because natural CBD is a FDA approved pharmaceutical known as EPIDIOLEX the FDA approval application is abbreviated(ANDA and not NEW (NDA)..in the case of treating ailments approved under "epidiolex" this is a generic...but this could additionally be For New treatments as a result of completed successful clinical trials by our pharmaceutical partner.....ED...this could very well be PIZER...
<< Previous
Bullboard Posts
Next >>